A case of panitumumab containing chemotherapy causing interstitial lung disease: early recognition and treatment resulting in a good outcome

Panitumumab is a recombinant human IgG(2) monoclonal antibody which is used for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or following FOLFIRI (fluoropyrimidine, oxaliplatin and irinotecan) containing chemotherapy regimen. We report a case of an 8...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Case Rep
Hlavní autoři: Rezkallah, Kamal Naguib Makar, Ahmed, Adnan, Patel, Sabah, Kozma, Kelly
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2019
Témata:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6441272/
https://ncbi.nlm.nih.gov/pubmed/30739089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-227785
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky